0001104659-21-088377.txt : 20210701 0001104659-21-088377.hdr.sgml : 20210701 20210701183012 ACCESSION NUMBER: 0001104659-21-088377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210701 DATE AS OF CHANGE: 20210701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edris Badreddin CENTRAL INDEX KEY: 0001786966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 211067398 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC. STREET 2: 100 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2121303d1_4.xml OWNERSHIP DOCUMENT X0306 4 2021-07-01 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001786966 Edris Badreddin C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Operating Officer Common Stock 2021-07-01 4 S 0 32000 85.3465 D 301541 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $82.01 to $87.12, inclusive Includes 101,038 restricted stock awards subject to time-based vesting. /s/ Francis I. Perier, Jr as Attorney-in-Fact 2021-07-01